1 Year Later: Medical Abortion After FDA Approval

On September 28, 2000, the Food and Drug Administration (FDA) approved mifepristone (RU486), the first dedicated medical abortion pill regimen. Many advocates on both sides of the abortion debate predicted that arrival of this new option would transform the abortion landscape – for women, for doctors, and for politicians. So, a year later, where are we?

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.